Human Genome DOWNGRADED to Neutral and 3 Stock Analyst-Downgraded Shares

July 16, 2012

Wall St. Watchdog reveals information about companies for which stock analysts downgraded the shares on July 16th.

Human Genome (NASDAQ:HGSI): Robert W. Baird downgraded its rating on this company from Outperform to Neutral and changed its price target to $14.

Don’t Miss: Why is Apple ALREADY Rejoining EPEAT?

Alpha Natural Resources (NYSE:ANR): BMO Capital Markets downgraded its rating on this company from Outperform to Underperform and changed its price target from $18 to $5.

Arch Coal (NYSE:ACI): BMO Capital Markets downgraded its rating on this company from Market Perform to Underperform and changed its price target from $10 to $4.

Clear Channel Outdoor (NYSE:CCO): Caris & Company downgraded its rating on this company from Above Average to Below Average.

Don’t Miss: Will Lower-Priced Lumia Shine a Light on Nokia?

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com